• REGIONS
  •  
  • Tech Focus
    • Autonomous Systems
    • Energy
    • Water
  • News
    • T2 News
    • Member Labs
    • FLC News
    • Submit an Article
    • Archive
    • T2 Tools
    • DC Perspective
    • Ready for Transfer
    • Lab Spotlight
  • Events
    • National Meetings
    • Current Year
    • Past Meetings
  • Media
    • Logo/Style-Guide
    • In the News
    • Press Releases
    • Editorial Calendar/Submissions
    • Publication Library
    • Video Library
  • Careers
  • Contact
  • Forum
  • Login
    • Facebook
    • Twitter
    • LinkedIn
    • Youtube
    • Flickr
    • Flickr
FLC Logo
  • About
    • History
    • Organization
    • Membership
    • Annual Reports
    • FLC Policies
    • Executive Board
    • Regional Contacts
    • Committees
    • National Advisory Council
    • Agency Representatives
    • Management Support
    • FLC Membership Application
     
  • Successes
    • Success Stories
    • Awards
    • LabTech in Your Life
    • Awards Gallery
    • 2018 FLC Award Winners
     
  • Learning Center
    • On Demand
    • Training Events
    • What is T2
    • Resources
    • Online Courses
    • Webinars
    • Reference Material
    • Training Videos
    • External Training Programs
    • Glossary
     
  • FLCBusiness
    • Laboratories
    • Available Technologies
    • Equipment
    • Funding
    • Facilities
    • Reference Materials
    • About
    • Contact
    • Notice of intent to license
     
  • T2 Toolkit
    • T2 Playbook
    • Technology Locator Service
    • T2 Mechanisms
    • Request Form
     
FLC Business
  • Learning Center
  • Publications
  • Media
  • Organization
  • Resources
  • Search Federallabs.org
    Displaying 121 - 150 of 32533
    available technology

    Quantitative Assay of the Angiogenic and Antiangiogenic Activity of a Test Molecule

    The invention provides a method of measuring the angiogenic or antiangiogenic activity of a test molecule. The method comprises obtaining an embryonated fowl egg, creating a window in the shell of the fowl egg, such that the CAM membrane is exposed, providing to a test region of interest on the CAM...
    Technology details Quick View
    available technology

    Identification of a Fusion/Entry Receptor for Human Herpesvirus-8

    This invention relates to stable, nonhuman cell lines and transgenic mammals having cells that coexpress human xCT as valuable tools for the continuing research of Kaposi’s Sarcoma Herpes Virus (KSHV) infection and the development of more effective anti-KSHV therapeutics. Kaposi’s sarcoma (KS) is...
    Technology details Quick View
    available technology

    Recombinant Plasmids Containing HIV Reverse Transcriptase

    NIH offers below HIV-1 Reverse Transcriptase (RT) Expression plasmids that are available for licensing via biological material licenses (BML). In an appropriate strain of E. coli, these plasmids cause the expression of an HIV-1 RT heterodimer (p66/p51). In the expression plasmid, the RT coding...
    Technology details Quick View
    available technology

    Recombinant Plasmids Containing HIV Reverse Transcriptase

    NIH offers below HIV-1 Reverse Transcriptase (RT) Expression plasmids that are available for licensing via biological material licenses (BML). In an appropriate strain of E. coli, these plasmids cause the expression of an HIV-1 RT heterodimer (p66/p51). In the expression plasmid, the RT coding...
    Technology details Quick View
    available technology

    Recombinant Plasmids Containing HIV Reverse Transcriptase

    NIH offers below HIV-1 Reverse Transcriptase (RT) Expression plasmids that are available for licensing via biological material licenses (BML). In an appropriate strain of E. coli, these plasmids cause the expression of an HIV-1 RT heterodimer (p66/p51). In the expression plasmid, the RT coding...
    Technology details Quick View
    available technology

    Novel 2-Alkoxy Estradiols and Derivatives Thereof

    The present invention is directed to novel 2-alkoxy estradiols and derivatives of 2-alkoxy estradiols having anticancer activity as claimed in the U.S. Patent 6,136,992. The invention is also directed to methods of preparing these novel compounds. These compounds have improved activity against a...
    Technology details Quick View
    available technology

    Spatially Selective Fixed-Optics Multicolor Fluorescence Detection System For Microfluidic Device

    Available for licensing and commercial development is a new scheme for sensitive spatially resolved and spectrally resolved laser-induced fluorescence detection from multiple microfluidic channels. The prototype instrument has been developed and is versatile in that it contains only fixed optical...
    Technology details Quick View
    available technology

    Biomarkers for Tissue Status

    Tissue regeneration and tumorigenesis are complex, adaptive processes controlled by cues from the host and from the tissue microenvironment. A variety of signals orchestrate the response to injury that results in regeneration and repair of a wound. Both tissue regeneration and carcinogenesis...
    Technology details Quick View
    available technology

    Recombinant Baculoviruses Containing Inserts of the Major Structural Genes (vp1) of the Human Polyomaviruses JCV...

    The development of sensitive and specific tests for JC virus and BK virus activity may provide tools essential in the steps required to find a treatment for these fatal infections. This invention describes a Recombinant Vpl protein (rVp1) that can be used 1) as an antigen source for ELISA assays 2...
    Technology details Quick View
    available technology

    New High-Throughput and Bioinformatic Tools to Identify and Use Genomic DNA Sequence Dimorphisms (Indels)

    This invention describes new methods to identify genomic DNA sequence dimorphisms called indels and to determine their biological consequences. "Indels" refers to large insertions and deletions, a form of variation in DNA sequences, that can cause genotypic and phenotypic differences between cells...
    Technology details Quick View
    available technology

    Novel System for HIV-1 Vaccine Development

    The available technologies describe specific immunogenic peptides, peptide modifications and methods for identifying additional immunogens against HIV-1 surface proteins, gp120 and gp41. Additionally, detailed methods for use of the described immunogenic peptides in the development of vaccines and...
    Technology details Quick View
    available technology

    Extracellular Matrix/Metastasis Modifier Genes as a Method for Characterization and Prevention of Metastatic Tumor...

    To a large extent cancer mortality is due to metastatic disease than a primary tumor. Recent evidence suggests that metastatic disease can be an early event and in majority of patients metastasis starts by the time the disease is diagnosed. Thus there is a need for methods of characterizing the...
    Technology details Quick View
    available technology

    Extracellular Matrix/Metastasis Modifier Genes as a Method for Characterization and Prevention of Metastatic Tumor...

    To a large extent cancer mortality is due to metastatic disease than a primary tumor. Recent evidence suggests that metastatic disease can be an early event and in majority of patients metastasis starts by the time the disease is diagnosed. Thus there is a need for methods of characterizing the...
    Technology details Quick View
    available technology

    Extracellular Matrix/Metastasis Modifier Genes as a Method for Characterization and Prevention of Metastatic Tumor...

    To a large extent cancer mortality is due to metastatic disease than a primary tumor. Recent evidence suggests that metastatic disease can be an early event and in majority of patients metastasis starts by the time the disease is diagnosed. Thus there is a need for methods of characterizing the...
    Technology details Quick View
    available technology

    Extracellular Matrix/Metastasis Modifier Genes as a Method for Characterization and Prevention of Metastatic Tumor...

    To a large extent cancer mortality is due to metastatic disease than a primary tumor. Recent evidence suggests that metastatic disease can be an early event and in majority of patients metastasis starts by the time the disease is diagnosed. Thus there is a need for methods of characterizing the...
    Technology details Quick View
    available technology

    Diagnosing and Treating Cancer Using beta-Catenin Splice Variants

    This application discloses and claims inventions which may be used alone or together. One group of inventions relates to early detection diagnostic, prognostic and patient monitoring methods (“Diagnostic Methods”). The other group of inventions relates to methods of treatment. Both groups of...
    Technology details Quick View
    available technology

    TMC1, a Deafness-Related Gene

    Hearing loss is a common communication disorder affecting nearly 1 in 1,000 children in the United States alone, and nearly 50% of adults by the age of eighty. Hearing loss can be caused by environmental and disease-related factors; however, hearing loss due to genetic factors accounts for...
    Technology details Quick View
    available technology

    Identification and Isolation of the Receptor for Pigment Epithelium-derived Factor (PEDF)

    This application describes and claims compositions and methods related to PEDF-R, a receptor for pigment epithelium-derived factor (PEDF). PEDF (akaserpin f1gene product) is a protein, belonging to the serpin superfamily with neurotrophic, gliastatic, neuronotrophic, antiangiogenic, and...
    Technology details Quick View
    available technology

    Genes Expressed in Prostate Cancer and Methods of Use

    This invention is a novel gene, called New Gene Expressed in Prostate (NGEP). This gene appears to be expressed only in human prostate and prostate cancer. This gene has two known splice variants of significantly different size. The shorter splice variant encodes a cytoplasmic protein, while the...
    Technology details Quick View
    available technology

    Epithelial Cell Line Expressing a Cystic Fibrosis Phenotype

    Cystic fibrosis (CF) is a common genetic disease that affects the entire body, producing thick, sticky mucus that clogs the lungs, pancreas, and other organs. It is the most common fatal genetic disease in the United States, and is caused by a mutation in the cystic fibrosis transmembrane...
    Technology details Quick View
    available technology

    Small Molecules for Imaging Protein-Protein Interactions

    Imaging techniques like positron emission tomography and photon emission computerized tomography are often used with imaging agents to detect the presence and accumulation of amyloid plaques within the human brain. These imaging agents have high specificity for beta amyloid peptides, and...
    Technology details Quick View
    available technology

    Chitosan as a Universal Vaccine Adjuvant, Antigen Depot and Cytokine Depot

    This technology describes the use of chitosan depots with appropriate antigens and/or cytokines for generating an immune response in a subject. Such depots are made by mixing one or more antigens and/or cytokines with chitosan or a chitosan derivative. Similar compositions are described wherein...
    Technology details Quick View
    available technology

    A Simian Immunodeficiency Virus Expressing HIV-1 Reverse Transcriptase for the Study of Antiviral Drug Resistance...

    Antiviral drug-resistance is the primary source for the decreased efficacy of currently available human immunodeficiency virus-1 (HIV-1) therapies. The available material provides a model system in which to test new antiviral treatment efficacy as well as the development of multi-drug-resistance to...
    Technology details Quick View
    available technology

    Novel Benzindole Based Compounds for HIV Therapy

    The HIV/AIDS epidemic continues despite efforts from scientists, drug companies, and non-profit organizations. Although the existing therapy, is effective in the treatment of many infected individuals in developed nations, the infected individual is not cured and therapy must be life-long. There...
    Technology details Quick View
    available technology

    Highly Soluble Pyrimido-Dione-Quinoline Compounds: Small Molecules that Stabilize and Activate p53 in Transformed...

    The tumor-suppressor p53 protein plays a major role in tumor development. Most human cancers ail to normally activate p53, which is at least partly responsible for the unregulated growth of cancer cells and their failure to undergo apoptosis. While many chemotherapeutics enhance p53 levels, their...
    Technology details Quick View
    available technology

    Methods and Systems for Identifying and Classifying Drug Targets

    Available for licensing and commercial development is a novel method for a-priori evaluation of the therapeutic relevance of gene products for various diseases, in order to make drug development more cost-efficient. In addition, this technology may be used to identify novel therapeutic uses for...
    Technology details Quick View
    available technology

    Modified Bacterial Strain for Otitis Media Vaccine

    This invention relates to a strain of Moraxella catarrhalis containing a gene mutation that prevents endotoxic lipooligosaccharide (LOS) synthesis and potential use of the mutant for developing novel vaccines against the pathogen, for which there is currently no licensed vaccine. M. catarrhalis is...
    Technology details Quick View
    available technology

    Organic Thiophosphate Antiretroviral Agents

    The current technology represents a potentially safe and effective addition to the antiretroviral drug combinations used for treatment of HIV infection. Amifostine, phosphonol and functional derivatives thereof are available for licensing and commercial development for use as antiretroviral drugs...
    Technology details Quick View
    available technology

    Novel Treatment of Vascular Cognitive Impairment

    Available for licensing are methods and formulations for treating or preventing Vascular Cognitive Impairment (VCI) through mucosal administration of E-selectin, an inducible adhesion molecule on endothelial cells. Vascular dementia is defined as the loss of cognitive function resulting from...
    Technology details Quick View
    available technology

    A Novel Magnetic Resonance Radio-Frequency Coil Array that Eliminates Inductive Coupling

    Parallel magnetic resonance imaging (MRI) techniques employ RF coil arrays for faster data acquisition, and have been shown to reduce the overall length of MRI procedures, improve signal-to–noise ratio (SNR) and image quality, thus making MRI more attractive and less costly. Elimination of...
    Technology details Quick View

    Pages

    • « first
    • ‹ previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • next ›
    • last »
    Favorite Added Test
    Click My Favorites to review all
    • Regions
    • Partners
    • Sitemap
    • 508 Compliance
    • Website User Agreement
    • Get the API

    Newsletter Signup

    2019 © Federal Laboratory Consortium for Technology Transfer
    • Contact Us
    • Facebook
    • Twitter
    • LinkedIn
    • Youtube
    • Flickr
    • IG

    2019 © Federal Laboratory Consortium for Technology Transfer